IRIS
MONTORSI, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 36.166
NA - Nord America 19.371
EU - Europa 15.999
SA - Sud America 11.739
AF - Africa 846
OC - Oceania 114
Continente sconosciuto - Info sul continente non disponibili 24
AN - Antartide 1
Totale 84.260
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.420
SG - Singapore 15.446
BR - Brasile 9.863
CN - Cina 8.734
HK - Hong Kong 5.683
SE - Svezia 4.491
IT - Italia 3.681
VN - Vietnam 3.118
RU - Federazione Russa 2.413
DE - Germania 1.146
RO - Romania 817
AR - Argentina 779
FI - Finlandia 717
IN - India 656
GB - Regno Unito 545
ID - Indonesia 497
CA - Canada 397
NL - Olanda 378
EC - Ecuador 349
MX - Messico 338
IE - Irlanda 337
BD - Bangladesh 306
JP - Giappone 280
IQ - Iraq 257
ZA - Sudafrica 257
FR - Francia 240
TR - Turchia 234
ES - Italia 216
AT - Austria 215
PL - Polonia 210
CO - Colombia 205
PY - Paraguay 151
UA - Ucraina 149
PK - Pakistan 120
MA - Marocco 117
CL - Cile 107
EG - Egitto 105
VE - Venezuela 103
UZ - Uzbekistan 98
AU - Australia 89
PE - Perù 79
IR - Iran 74
SA - Arabia Saudita 74
UY - Uruguay 67
LT - Lituania 63
AE - Emirati Arabi Uniti 60
KE - Kenya 60
NG - Nigeria 58
TN - Tunisia 57
DZ - Algeria 52
NP - Nepal 51
DO - Repubblica Dominicana 49
AZ - Azerbaigian 48
CH - Svizzera 48
JO - Giordania 46
BE - Belgio 41
IL - Israele 38
KZ - Kazakistan 37
MY - Malesia 35
KR - Corea 34
TW - Taiwan 33
CZ - Repubblica Ceca 29
GR - Grecia 29
BG - Bulgaria 27
JM - Giamaica 26
BO - Bolivia 25
AL - Albania 24
HN - Honduras 24
NO - Norvegia 21
RS - Serbia 21
BH - Bahrain 20
OM - Oman 20
PH - Filippine 20
KW - Kuwait 19
LB - Libano 19
TH - Thailandia 18
CR - Costa Rica 17
PT - Portogallo 17
SN - Senegal 17
TT - Trinidad e Tobago 17
BA - Bosnia-Erzegovina 16
GT - Guatemala 16
PA - Panama 16
TZ - Tanzania 16
BY - Bielorussia 15
DK - Danimarca 15
PS - Palestinian Territory 15
SV - El Salvador 15
BB - Barbados 14
XK - ???statistics.table.value.countryCode.XK??? 14
HU - Ungheria 13
NZ - Nuova Zelanda 13
SC - Seychelles 13
HR - Croazia 12
AO - Angola 10
ET - Etiopia 10
KG - Kirghizistan 10
MK - Macedonia 10
AM - Armenia 9
CI - Costa d'Avorio 9
Totale 84.039
Salva come PNG Salva come JPEG
Città #
Singapore 5.978
Hong Kong 5.648
Dallas 4.971
Hefei 2.271
Shanghai 2.233
Lawrence 2.119
Princeton 2.113
Ashburn 1.946
Ho Chi Minh City 1.194
Moscow 1.080
Milan 829
São Paulo 763
New York 754
Beijing 744
Hanoi 642
Helsinki 534
Los Angeles 459
Rio de Janeiro 338
Dublin 332
Munich 291
Boardman 278
Rome 260
Belo Horizonte 209
Nuremberg 203
Brasília 188
Pune 162
Tokyo 162
Brooklyn 160
Warsaw 160
Curitiba 153
Montreal 143
Porto Alegre 135
Santa Clara 134
Guangzhou 132
Turku 132
Haiphong 127
Johannesburg 127
Denver 126
Campinas 123
Da Nang 115
The Dalles 114
Guayaquil 112
Chennai 111
Quito 110
Atlanta 108
Vienna 103
Biên Hòa 102
Stockholm 101
Turin 101
Columbus 100
Seattle 100
Guarulhos 99
Salvador 96
Washington 91
Thái Bình 90
London 88
Orem 87
Chicago 86
Jakarta 84
Ribeirão Preto 84
Poplar 83
Tashkent 83
Toronto 83
Boston 82
Tianjin 81
Phoenix 80
Baghdad 78
Naples 77
Frankfurt am Main 76
Hangzhou 76
Houston 75
Hải Dương 75
Goiânia 72
Manaus 72
Fortaleza 71
Mexico City 71
Recife 71
Bologna 70
Manchester 70
Caxias do Sul 66
Buenos Aires 63
Dhaka 63
Ankara 61
Mumbai 61
Sumaré 61
Amsterdam 60
Santo André 60
Council Bluffs 59
Florence 59
Valencia 59
Istanbul 58
Osasco 58
Ninh Bình 56
San Francisco 54
Montevideo 53
Sorocaba 51
Cape Town 50
Paris 50
Erbil 49
Lima 49
Totale 43.081
Salva come PNG Salva come JPEG
Nome #
External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection 1.615
(11)C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms 1.361
Worldwide Temporal Trends in Penile Length: A Systematic Review and Meta-Analysis 457
Benign Prostatic Hyperplasia and Its Aetiologies 422
Improved prediction of disease relapse after radical prostatectomy through a panel of preoperative blood-based biomarkers 372
A Novel RGD-4C-Saporin Conjugate Inhibits Tumor Growth in Mouse Models of Bladder Cancer 341
High serum alpha-fetoprotein levels in primary infertile men 328
Women's sexual dysfunction: a pathophysiological review 275
Sexual dysfunction is common in women with lower urinary tract symptoms and urinary incontinence: Results of a cross-sectional study 177
Indications for Pelvic Nodal Treatment in Prostate Cancer Should Change. Validation of the Roach Formula in a Large Extended Nodal Dissection Series 173
[18F]Fluoro-Deoxy-Glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving neoadjuvant pembrolizumab 162
Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease 146
A comparative review of apomorphine formulations for erectile dysfunction - Recommendations for use in the elderly 134
Organic vs. Psychogenic? The Manichean Diagnosis in Sexual Medicine 132
"Case of the month from San Raffaele Hospital, Milan, Italy: paraneoplastic presentation of small renal masses" 131
[68Ga]Ga-PSMA and [68Ga]Ga-RM2 PET/MRI vs. Histopathological Images in Prostate Cancer: A New Workflow for Spatial Co-Registration 125
11C-choline PET/CT predicts prostate cancer-specific survival in patients with biochemical failure during androgen-deprivation therapy 121
[11C]choline positron emission tomography/computerized tomography to restage prostate cancer cases with biochemical failure after radical prostatectomy and no disease evidence on conventional imaging 112
A comprehensive assessment of frailty status on surgical, functional and oncologic outcomes in patients treated with partial nephrectomy––A large, retrospective, single-center study 111
[ 11C] Choline PET/CT Predicts Prostate Cancer-Specific Survival in Patients with Biochemical Failure During Androgen Deprivation Therapy 108
[C-11]Choline PET/CT predicts survival in hormone-naive prostate cancer patients with biochemical failure after radical prostatectomy 107
Are finasteride-related penile curvature/Peyronie's disease Adverse Event Reports worthy of further clinical investigation? Disproportionality analysis based on both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases 106
Impact of prostate imaging quality (PI-QUAL) score on the detection of clinically significant prostate cancer at biopsy 106
Lymphatic spread of nodal metastases in high-risk prostate cancer: The ascending pathway from the pelvis to the retroperitoneum 106
Aging, inflammation and DNA damage in the somatic testicular niche with idiopathic germ cell aplasia 104
[11C]CHOLINE PET/CT SCAN PREDICTS SURVIVAL IN PROSTATE CANCER PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY 103
120-MONTH MEDIAN FOLLOW-UP OF INTRACAVERNOUS INJECTION THERAPY FOR ERECTILE DYSFUNCTION 103
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 103
Normal sperm parameters per se do not reliably account for fertility: A case–control study in the real-life setting 102
Updated Nomogram Predicting Lymph Node Invasion in Patients with Prostate Cancer Undergoing Extended Pelvic Lymph Node Dissection: The Essential Importance of Percentage of Positive Cores 100
Sildenafil taken at bedtime significantly increases nocturnal erections: Results of a placebo-controlled study 100
Nasal congestion after visual sexual stimulation with and without sildenafil (Viagra (R)): a randomized placebo-controlled study 100
11C-CHOLINE-POSITRON EMISSION TOMOGRAPHY/ COMPUTERISED TOMOGRAPHY FOR PREOPERATIVE LYMPH- NODE STAGING IN INTERMEDIATE-RISK AND HIGH-RISK PROSTATE CANCER: COMPARISON WITH CLINICAL STAGING NOMOGRAMS 100
A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies 100
ROBOT-ASSISTED RADICAL PROSTATECTOMY IS ASSOCIATED WITH FASTER AND GREATER RECOVERY FROM ORGASM ASSOCIATED INCONTINENCE 100
A NOVEL MODEL INTEGRATING CLINICAL, MP-MRI, AND EPIGENOMIC FEATURES TO PREDICT LYMPH NODE INVASION IN PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY AND PELVIC LYMPH NODE DISSECTION 99
A CRITICAL APPRAISAL OF THE ABILITY OF BODY MASS INDEX (BMI) TO PREDICT HIGH-GRADE PROSTATE CANCER (PCA) 99
A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation 99
68Ga-PSMA-PET/CT Scan as Primary Staging for Prostate Cancer and Its Related Clinical Implications 99
4-DRUG INTRACAVERNOUS THERAPY FOR IMPOTENCE DUE TO CORPOREAL VENOOCCLUSIVE DYSFUNCTION 96
Effect of yohimbine-trazodone on psychogenic impotence: a randomized, double-blind, placebo-controlled study. 95
30-DAY MORTALITY AFTER RADICAL PROSTATECTOMY IN OVER 9000 PATIENTS: VALIDATION OF A PREDICTIVE NOMOGRAM 94
[In Process Citation]. FT Doit-on porter des lunettes protectrices lors de l'utilisation du laser Holmium:YAG lors des procedures endourologiques? Etude chez un modele animal. 93
[Management of erectile dysfunction in patients with preexisting cardiovascular disease]. FT Disfunzione erettile nel paziente cardiopatico: diagnosi e raccomandazioni terapeutiche. 92
[C-11] Choline Positron Emission Tomography/Computerized Tomography for Early Detection of Prostate Cancer Recurrence in Patients with Low Increasing Prostate Specific Antigen 92
A critical analysis of Permixon (TM) in the treatment of lower urinary tract symptoms due to benign prostatic enlargement 91
A mechanistic insight into the anti-metastatic role of the prostate specific antigen 91
Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer 90
Hyperestrogenism is associated with sexual function impairment in men-findings from a cross-sectional, real-life study 89
A MINIMUM OF 14 CORES SHOULD BE TAKEN AT BIOPSY BEFORE PLANNING ACTIVE SURVEILLANCE FOR PATIENTS WITH LOW-RISK PROSTATE CANCER 89
Pelvic lymph node dissection in prostate cancer 89
Pelvic/Retroperitoneal Salvage Lymph Node Dissection for Patients Treated With Radical Prostatectomy With Biochemical Recurrence and Nodal Recurrence Detected by [11C]Choline Positron Emission Tomography/Computed Tomography 89
Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer 89
How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series 89
Gold nanorod–assisted theranostic solution for nonvisible residual disease in bladder cancer 88
[Not Available]. FT Doit-on porter des lunettes protectrices lors de l'utilisation du laser Holmium:YAG lors des procedures endourologiques? Etude chez un modele animal. 88
Prediction of Sexual Function After Radical Prostatectomy 88
The Importance of Discordant Follicle Stimulating Hormone and Inhibin B Levels in Primary Infertile Men: Findings from a Cross-Sectional Study 86
A critical analysis of laser prostatectomy in the management of benign prostatic hyperplasia 86
Association Between Human Papillomavirus Infection and Outcome of Perioperative Nodal Radiotherapy for Penile Carcinoma 86
Prostate-specific antigen velocity versus prostate-specific antigen doubling time for prediction of 11C choline PET/CT in prostate cancer patients with biochemical failure after radical prostatectomy 85
Quantitative sensory testing of peripheral thresholds in patients with lifelong premature ejaculation: a case-controlled study 85
[Management and prevention of catheter-associated urinary tract infections: current opinions and clinical practice]. FT Gestione e prevenzionedelle infezioni delle vieurinarie associate a catetere:opinioni e pratica clinica. 85
A nomogram for staging of exclusive nonobturator lymph node metastases in men with localized prostate cancer 85
Clinical Profile of Young Patients with Erectile Dysfunction: Preliminary Findings of a Real-life Cross-sectional Study 85
Acute Kidney Injury at Hospital Admission for SARS-CoV-2 Infection as a Marker of Poor Prognosis: Clinical Implications for Triage Risk Stratification 85
Androgen annihilation versus advanced androgen blockage as first line treatment for metastatic castration resistant prostate cancer: A systematic review and meta-analysis 84
A global approach to improving penile cancer care 84
Medications mostly associated with priapism events: assessment of the 2015-2020 Food and Drug Administration (FDA) pharmacovigilance database entries 83
Radiomic and gEnomic approaches for the enhanced DIagnosis of clear cell REnal Cancer (REDIRECt): a translational pilot methodological study 83
Long-term safety and tolerability of thdalafil in the treatment of erectile dysfunction 83
Association between erectile dysfunction and coronary artery disease: Matching the right target with the right test in the right patient 83
Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy. 81
Prediction of Functional Outcomes After Nerve-Sparing Radical Prostatectomy: Results of Conditional Survival Analyses 81
Holmium laser enucleation of the prostate versus open prostatectomy for prostates > 70 g: 24-month follow-up 80
Centralization of care for rare genetic syndromes associated with cancer: improving outcomes and advancing research on VHL disease 79
[11C]CHOLINE PET/CT FOR RESTAGING PROSTATE CANCER PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY AND NO EVIDENCE OF DISEASE ON CONVENTIONAL IMAGING 79
Can We Rely Solely on the International Prostate Symptoms Score to Investigate Storage Symptoms in Men with Lower Urinary Tract Symptoms Associated with Benign Prostatic Enlargement? Findings from a Cross-sectional Study 79
Rates and predictors of postoperative complications after Holmium laser enucleation of the prostate (HoLEP) at a high-volume center 79
Correlation among isolated teratozoospermia, sperm DNA fragmentation and markers of systemic inflammation in primary infertile men 79
Efficacy and toxicity of antibody-drug conjugates in the treatment of metastatic urothelial cancer: A scoping review 79
Chemotherapy and advanced androgen blockage, alone or combined, for metastatic hormone-sensitive prostate cancer a systematic review and meta-analysis 78
Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study 78
PROSTATIC UROLUME WALLSTENT FOR BENIGN PROSTATIC HYPERPLASIA PATIENTS AT POOR OPERATIVE RISK - CLINICAL, UROFLOWMETRIC AND ULTRASONOGRAPHIC PATTERNS 78
ADC in the evaluation of side-specific extracapsular extension of prostate cancer: development and internal validation of a nomogram of clinical utility 78
Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool 76
Accurate prediction of long-term risk of biochemical failure after salvage radiotherapy including the impact of pelvic node irradiation 76
Clinical Comparison of Holmium Laser Enucleation of the Prostate and Bipolar Transurethral Enucleation of the Prostate in Patients Under Either Anticoagulation or Antiplatelet Therapy 76
Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Carcinoma with Variant Histologies 76
How to Select the Optimal Candidates for Renal Mass Biopsy 76
Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard 75
Risks and benefits of partial nephrectomy performed with limited or with zero ischaemia time 75
Haemospermia in the Real- Life Setting: A New High-Risk Stratification 75
Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma 74
A review on pharmacological options for the treatment of erectile dysfunction: state of the art and new strategies 74
[Not Available]. FT Second-look precoce par ureteroscopie souple apres traitement endoscopique conservatif pour tumeur de la voie excretrice urinaire superieure: resultats preliminaires. 73
A critical analysis of vardenafil in the management of patients with erectile dysfunction: an integration of the literature and collective personal experience. 73
The Role of Choline Positron Emission Tomography/Computed Tomography in the Management of Patients with Prostate-Specific Antigen Progression After Radical Treatment of Prostate Cancer 73
Preoperative Erectile Function Represents a Significant Predictor of Postoperative Urinary Continence Recovery in Patients Treated With Bilateral Nerve Sparing Radical Prostatectomy 73
Pembrolizumab in advanced renal cell carcinoma: a meta-analysis providing level 1a evidence 72
Totale 13.784
Salva come PNG Salva come JPEG
Categoria #
all - tutte 758.217
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 758.217
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021161 0 0 0 0 0 124 8 2 11 6 8 2
2021/20221.273 1 58 30 577 61 65 90 75 42 69 55 150
2022/202310.126 4.873 1.738 601 119 68 1.013 434 606 272 96 151 155
2023/20245.160 235 279 399 356 413 922 292 508 90 383 562 721
2024/202529.158 4.249 726 542 672 691 2.350 4.169 2.213 5.247 4.330 1.813 2.156
2025/202638.978 5.690 7.391 7.341 12.527 5.552 477 0 0 0 0 0 0
Totale 85.452